Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Preservation Bio's Novel Additive Enables Long-Term Platelet Storage in Refrigeration, with the Potential to Address Major National Blood Supply Challenge

      Preservation Bio

      News provided by

      Preservation Bio

      Aug 21, 2024, 06:00 ET

      Share this article

      Share this article


      With U.S. Blood Donations at a 20-Year Low, New Research Published in the Journal Blood Demonstrates How the Additive Could Extend Platelet Storage to 14 Days, Significantly Reducing Contamination Risk and Waste

      CINCINNATI, Aug. 21, 2024 /PRNewswire/ -- Preservation Bio, a leader in platelet preservation technology, today announced a major advancement in transfusion medicine, validated by a pivotal study published in the prestigious journal Blood. The research, led by Preservation Bio's scientific co-founders, Dr. Jose Cancelas and Dr. Yi Zheng, introduces an innovative ex vivo platelet additive that could revolutionize blood banking by enabling long-term cold storage of platelets. The United States is facing a severe crisis in the blood supply chain, with the American Red Cross reporting the lowest number of blood donors in 20 years. This blood shortage has significant implications, particularly for platelet supplies, which are essential for many life-saving medical procedures.

      Preservation Bio's innovative ex vivo platelet additive addresses this critical blood supply challenge by enabling the long-term cold storage of platelets for up to 14 days. This breakthrough in refrigeration offers several key advantages, including the potential to extend platelet shelf life well beyond the current 5-7 days, thereby reducing seasonal and regional fluctuations in platelet supply and minimizing waste.

      "Our innovation represents a promising advancement in platelet storage that could address some of the most pressing challenges in transfusion medicine," said Dr. Jose Cancelas, scientific co-founder of Preservation Bio. "By extending platelet shelf life and reducing the risk of contamination, our additive aims to enhance patient safety and ensure that every donation has the maximum impact, especially at a time when the blood supply is critically low. While we are still in the early stages of development, we are hopeful that this additive could pave the way for a more reliable global platelet supply."

      By significantly enhancing storage quality and safety with refrigeration, Preservation Bio's ex vivo platelet additive reduces the risk of bacterial contamination associated with traditional room temperature storage methods. The additive is versatile enough to support the production of long-term stored platelets across various platforms, ensuring they are suitable for transfusion in all patient groups. This flexibility allows blood centers and hospitals to maintain a unified inventory that can serve both trauma patients and those with hematologic conditions, simplifying logistics and improving resource allocation. These advancements could play a crucial role in stabilizing the platelet supply and easing the burden of declining donation rates.

      "Our ex vivo additive not only protects platelets from cold lesions but also induces a 'reversible hibernated' state, preserving their functionality after extended cold storage," said Dr. Yi Zheng, an expert in RHOA biochemistry and scientific co-founder at Preservation Bio. "This additive has the potential to fundamentally change how we approach platelet storage and transfusions in the future."

      The study in Blood, titled "Inhibition of RHOA Activity Preserves the Survival and Hemostasis Function of Long-Term Cold Stored Platelets," presents these key findings:

      • RHOA GTPase Activation Identified: The study identified RHOA GTPase activation as a key molecular switch controlling cold platelet storage lesions.
         
      • Development of RHoA Inhibitors: RHOA chiral enantiomer inhibitors (R-G04 and S-G04) were developed to effectively prevent cold storage-induced damage.
         
      • Prolonged Survival and Function: Cold-stored platelets treated with these inhibitors for up to 14 days maintained survival and hemostatic function comparable to 5-7 days for room temperature stored platelets.
         
      • Prevention of Cold Damage: The inhibitors act by blocking the key regulator of cold-induced damage, preventing multiple biochemical, structural and functional problems of cold-stored platelets resulting in platelet clearance and hemostatic dysfunction.
         
      • Prevention of Bacterial Growth: The inhibitors will prevent bacterial growth and allow cold storage of platelets amenable to be transfused to essentially all patients in need including immunodeficient cancer patients.
         
      • Potential for Clinical Application: The inhibitors preserved clotting activity of human platelets transfused and corrected the excess bleeding in animals with reduced platelet count and/or deficient activity, supporting an application for clinical transfusion.

      Dr. Pampee Young, Chief Medical Officer of Biomedical Services at the American Red Cross, added, "This groundbreaking advancement in platelet storage technology is set to revolutionize care for cancer and trauma patients. Traditionally, cold-stored platelets, known for their superior ability to stop bleeding, have been quickly cleared from the body, limiting their clinical use. But now, Preservation Bio's cutting-edge approach that inhibits RHOA activity has been shown to preserve the function and extend the lifespan of these platelets, making them viable for longer and safer use. This innovation represents a transformative advancement in transfusion medicine, and can address critical challenges in both the availability and safety of platelet transfusions."

      "We are excited to move this research closer to becoming a commercial product that could significantly help patients requiring platelet transfusions," said Rich Ganz, CEO of Preservation Bio and Senior Venture Partner at Orange Grove Bio. "By enhancing the safety and availability of platelets, our goal is to support healthcare providers and improve patient outcomes, particularly as we face ongoing challenges with declining blood donations."

      Preservation Bio is preparing to file an IND and initiate a Phase 1 clinical trial at the Hoxworth Blood Center in Cincinnati and the American Red Cross in Virginia. The key endpoints will be platelet survival and recovery. Following successful Phase 1 results, Preservation Bio plans to conduct a pivotal trial at major cancer centers in the United States.

      About Preservation Bio

      Preservation Bio, a subsidiary of Orange Grove Bio, is pioneering advancements in transfusion medicine with its innovative ex vivo platelet additive. This platelet preservation technology has the potential to extend platelet shelf life to 14 days under refrigeration, addressing critical challenges in the blood supply chain amid a national donation crisis. By significantly reducing contamination risks and enhancing platelet availability, Preservation Bio aims to revolutionize blood banking and improve patient outcomes. For more information about Preservation Bio and its platelet preservation technology, please visit www.orangegrovebio.com.

      Media Contact:
      Chris Hempel
      Spark Public Relations
      [email protected]

      SOURCE Preservation Bio

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.